The aptamer market is experiencing significant growth, driven by an array of factors that enhance its appeal across various applications, including diagnostics, therapeutics, and research. Aptamers, which are short, single-stranded oligonucleotides that can selectively bind to specific targets, offer unique advantages over traditional antibodies. Their ability to be engineered for specificity,...
0 Commentarios
0 Acciones
398 Views
0 Vista previa